Trial design
Thermic-3 is a single-centre, parallel-group RCT. Participants were allocated in a 1:1 ratio to receive either antegrade ICBC or IWBC. Participants were followed-up for 3 months after randomization. Details of the study rationale and design are reported elsewhere [